Antibacterial Agents
34
5
6
20
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.9%
2 terminated out of 34 trials
90.9%
+4.4% vs benchmark
18%
6 trials in Phase 3/4
35%
7 of 20 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 20 completed trials
Clinical Trials (34)
Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa
Acute Application of Antibiotic Powder in Open Fracture Wounds
Improving Antibiotic Use for ARIs in Urgent Care Clinics
Evaluation of a Customizable Antibiotic Stewardship Program Tailored to French Nursing Homes
CAT BITE Antibiotic Prophylaxis for the Hand/Forearm (CATBITE)
Modulation of Gut MicroFLORA With Rifaximin to Reduce High Platelet Reactivity in Post-ACS Patients on Ticagrelor
The Impact of De-implementing Urine Dipsticks for Diagnosis of UTIs in Hospitals
The Expected Advantage of Administering Prophylactic Antibiotics Using Target- Concentration Controlled Infusion
Pharmacokinetics of Meropenem and Aztreonam After Intraperitoneal Administration Via Cycler-therapy in APD Patients Without Peritonitis
Antibiotic Treatment for Pneumonia Caused by Stenotrophomonas Maltophilia in ICU Patients
Use of Macrolides in Acute Chest Syndrome: A Multicenter Retrospective Study
Single Dose Versus 24 Hours Antibiotic Prophylaxis in Reduction Mammaplasty
Effect of Calcium Silicate-Based Root Canal Medicament After Retreatment
Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai Portoenterostomy
Neuroimmune Dysfunction in Alcohol Use Disorder
7 Days Versus 14 Days of Antibiotics for Neonatal Sepsis
Azithromycin to Improve Latency in Exam Indicated Cerclage Control Trial
Healthy Patients & Effect of Antibiotics
Plasma Protein Binding and PK/PD of Total and Unbound Temocillin Non-ICU Patients
Population Pharmacokinetics and Pharmacodynamics of Beta-lactams of Interest in Adult Patients From Intensive Care Units